Detalhe da pesquisa
1.
Altered cytokine and chemokine profiles in multiple myeloma and its precursor disease.
Cytokine
; 69(2): 294-7, 2014 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-25043675
2.
Oncology drug development: what is changing?
Clin J Oncol Nurs
; 12(5): 713-5, 2008 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-18842527
3.
Modeling progression risk for smoldering multiple myeloma: results from a prospective clinical study.
Leuk Lymphoma
; 54(10): 2215-8, 2013 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-23311294
4.
A phase I combination study of olaparib with cisplatin and gemcitabine in adults with solid tumors.
Clin Cancer Res
; 18(8): 2344-51, 2012 Apr 15.
Artigo
Inglês
| MEDLINE | ID: mdl-22371451
5.
A case study progression to multiple myeloma.
Clin J Oncol Nurs
; 14(4): 419-22, 2010 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-20682498
6.
Phase I trial of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG), a heat shock protein inhibitor, administered twice weekly in patients with advanced malignancies.
Eur J Cancer
; 46(2): 340-7, 2010 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-19945858
7.
Sezary syndrome: a case study of cutaneous T-cell lymphoma.
Clin J Oncol Nurs
; 13(2): 157-9, 2009 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-19349262